Burning Rock Biotech (BNR) Accounts Payables (2021 - 2023)

Burning Rock Biotech has reported Accounts Payables over the past 3 years, most recently at $2.5 million for Q4 2023.

  • Quarterly results put Accounts Payables at $2.5 million for Q4 2023, down 64.98% from a year ago — trailing twelve months through Dec 2023 was $2.5 million (down 64.98% YoY), and the annual figure for FY2023 was $2.5 million, down 66.47%.
  • Accounts Payables for Q4 2023 was $2.5 million at Burning Rock Biotech, down from $7.2 million in the prior quarter.
  • Over the last five years, Accounts Payables for BNR hit a ceiling of $9.9 million in Q4 2021 and a floor of $2.5 million in Q4 2023.
  • Median Accounts Payables over the past 3 years was $7.2 million (2022), compared with a mean of $6.5 million.
  • Biggest five-year swings in Accounts Payables: dropped 27.4% in 2022 and later tumbled 64.98% in 2023.
  • Burning Rock Biotech's Accounts Payables stood at $9.9 million in 2021, then fell by 27.4% to $7.2 million in 2022, then tumbled by 64.98% to $2.5 million in 2023.
  • The last three reported values for Accounts Payables were $2.5 million (Q4 2023), $7.2 million (Q4 2022), and $9.9 million (Q4 2021) per Business Quant data.